{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:58:35Z","timestamp":1790873915886,"version":"4.1.0"},"reference-count":158,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973787"],"award-info":[{"award-number":["81973787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004846","name":"Beijing University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7254502"],"award-info":[{"award-number":["7254502"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tjpad.2025.100193","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T14:57:55Z","timestamp":1746111475000},"page":"100193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Value of blood neural cell-derived small extracellular vesicles in the diagnosis and prediction of Alzheimer's disease: A systematic review"],"prefix":"10.1016","volume":"12","author":[{"given":"Weibing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxue","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100193_bib0001","article-title":"World Alzheimer Report 2023: reducing dementia risk: never too early, never too late","year":"2023","journal-title":"Alzheimer's Dis. Int."},{"issue":"16","key":"10.1016\/j.tjpad.2025.100193_bib0002","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1474-4422(19)30290-X","article-title":"Dementia in China: epidemiology, clinical management, and research advances","volume":"19","author":"Jia","year":"2020","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100193_bib0004","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100193_bib0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100193_bib0006","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100193_bib0007","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1002\/alz.14057","article-title":"The link between gut microbiome and Alzheimer's disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer's disease","volume":"20","author":"Liang","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"8024","key":"10.1016\/j.tjpad.2025.100193_bib0008","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/d41586-024-02535-x","article-title":"Blood tests could soon predict your risk of Alzheimer's","volume":"632","author":"Abbott","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0009","first-page":"993","article-title":"A panel of blood biomarkers for the diagnosis of transient ischemic attacks","volume":"10","author":"Guam\u00e1n-Pilco","year":"2025","journal-title":"Cardiovasc Innov Appl"},{"issue":"15","key":"10.1016\/j.tjpad.2025.100193_bib0010","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect Alzheimer disease in primary care and secondary care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100193_bib0011","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/alz.14315","article-title":"Head-to-head comparison of leading blood tests for Alzheimer's disease pathology","volume":"20","author":"Schindler","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100193_bib0012","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/alz.12546","article-title":"APP accumulates with presynaptic proteins around amyloid plaques: a role for presynaptic mechanisms in Alzheimer's disease?","volume":"18","author":"Jorda-Siquier","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100193_bib0013","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jalz.2015.12.005","article-title":"Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability","volume":"12","author":"de Wilde M","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0014","doi-asserted-by":"crossref","first-page":"fcab79","DOI":"10.1093\/braincomms\/fcab079","article-title":"Distinctive alteration of presynaptic proteins in the outer molecular layer of the dentate gyrus in Alzheimer's disease","volume":"3","author":"Haytural","year":"2021","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1074\/mcp.RA119.001737","article-title":"The proteome of the dentate terminal zone of the perforant path indicates presynaptic impairment in Alzheimer disease","volume":"19","author":"Haytural","year":"2020","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0017","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.3122\/jabfm.2012.02.120023","article-title":"Introduction from the Agency for Healthcare Research and Quality","volume":"25","author":"Meyers","year":"2012","journal-title":"J Am Board Fam Med"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100193_bib0018","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100193_bib0019","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1002\/alz.13055","article-title":"MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease","volume":"19","author":"Kumar","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"s1","key":"10.1016\/j.tjpad.2025.100193_bib0020","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.3233\/JAD-220829","article-title":"Pathological (Dis)similarities in neuronal exosome-derived synaptic and organellar marker levels between Alzheimer's Disease and frontotemporal dementia","volume":"94","author":"Krishna","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100193_bib0021","article-title":"Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease","author":"Tian","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100193_bib0022","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s12031-022-02012-y","article-title":"Alteration of miRNAs in small neuron-derived extracellular vesicles of Alzheimer's Disease patients and the effect of extracellular vesicles on microglial immune responses","volume":"72","author":"Durur","year":"2022","journal-title":"J Mol Neurosci"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030436","article-title":"Neuronal-derived EV biomarkers track cognitive decline in Alzheimer's disease","volume":"11","author":"Eren","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100193_bib0024","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.55730\/1300-0144.5484","article-title":"Determination of miR-373 and miR-204 levels in neuronal exosomes in Alzheimer's disease","volume":"52","author":"Tasdelen","year":"2022","journal-title":"Turk J Med Sci"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13195-022-01010-x","article-title":"beta-amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer's disease and predicts cerebral amyloidosis","volume":"14","author":"Li","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0026","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-220575","article-title":"Modulation of amyloid-beta and tau in Alzheimer's Disease plasma neuronal-derived extracellular vesicles by cerebrolysin(R) and Donepezil","volume":"90","author":"Alvarez","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100193_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105800","article-title":"MicroRNA-29c-3p in dual-labeled exosome is a potential diagnostic marker of subjective cognitive decline","volume":"171","author":"Li","year":"2022","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.tjpad.2025.100193_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135914","article-title":"Proteome profiling of neuron-derived exosomes in Alzheimer's disease reveals hemoglobin as a potential biomarker","volume":"755","author":"Arioz","year":"2021","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.tjpad.2025.100193_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.696944","article-title":"Discovery of novel markers for identifying cognitive decline using neuron-derived exosomes","volume":"13","author":"Zhong","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/alz.12166","article-title":"Blood neuro-exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage","volume":"17","author":"Jia","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100193_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111587","article-title":"Mitochondrial electron transport chain protein abnormalities detected in plasma extracellular vesicles in Alzheimer's disease","volume":"9","author":"Yao","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0032","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40035-020-00210-5","article-title":"Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia","volume":"9","author":"Zhao","year":"2020","journal-title":"Transl Neurodegener"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100193_bib0033","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/acn3.51155","article-title":"Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer's disease","volume":"7","author":"Gu","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"14","key":"10.1016\/j.tjpad.2025.100193_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145007","article-title":"Serum tau proteins as potential biomarkers for the assessment of Alzheimer's Disease progression","volume":"21","author":"Nam","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100193_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061443","article-title":"MiRNA profiling in plasma neural-derived small extracellular vesicles from patients with Alzheimer's disease","volume":"9","author":"Serpente","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tjpad.2025.100193_bib0036","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fnagi.2020.00166","article-title":"TDP-43 is elevated in plasma neuronal-derived exosomes of patients with Alzheimer's disease","volume":"12","author":"Zhang","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.tjpad.2025.100193_bib0037","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.dadm.2018.11.002","article-title":"Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementia","volume":"11","author":"Winston","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100193_bib0038","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1007\/s12035-019-1501-x","article-title":"SNAP-25 in serum is carried by exosomes of neuronal origin and is a potential biomarker of Alzheimer's disease","volume":"56","author":"Agliardi","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.tjpad.2025.100193_bib0039","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3389\/fnins.2019.01208","article-title":"miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of Alzheimer's patients","volume":"13","author":"Cha","year":"2019","journal-title":"Front Neurosci"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100193_bib0040","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamaneurol.2019.2462","article-title":"Association of extracellular vesicle biomarkers with Alzheimer Disease in the Baltimore Longitudinal Study of aging","volume":"76","author":"Kapogiannis","year":"2019","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100193_bib0041","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jalz.2019.05.002","article-title":"Concordance between the assessment of Abeta42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid","volume":"15","author":"Jia","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0042","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3233\/JAD-180302","article-title":"Growth hormone-releasing hormone modulation of neuronal exosome biomarkers in mild cognitive impairment","volume":"66","author":"Winston","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0043","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1096\/fj.201700731R","article-title":"Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease","volume":"32","author":"Goetzl","year":"2018","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0044","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.25172","article-title":"High complement levels in astrocyte-derived exosomes of Alzheimer disease","volume":"83","author":"Goetzl","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tjpad.2025.100193_bib0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dadm.2016.04.001","article-title":"Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile","volume":"3","author":"Winston","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100193_bib0046","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1096\/fj.201600756R","article-title":"Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100193_bib0047","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1096\/fj.201600816R","article-title":"Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100193_bib0048","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/acn3.309","article-title":"Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging","volume":"3","author":"Abner","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0049","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1096\/fj.14-262048","article-title":"Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease","volume":"29","author":"Kapogiannis","year":"2015","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","article-title":"Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease","volume":"85","author":"Goetzl","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100193_bib0051","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/acn3.211","article-title":"Low neural exosomal levels of cellular survival factors in Alzheimer's disease","volume":"2","author":"Goetzl","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100193_bib0052","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","article-title":"Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study","volume":"11","author":"Fiandaca","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100193_bib0053","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70725","article-title":"Framework for rapid comparison of extracellular vesicle isolation methods","volume":"10","author":"Ter-Ovanesyan","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.tjpad.2025.100193_bib0054","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27031","article-title":"Optimized exosome isolation protocol for cell culture supernatant and human plasma","volume":"4","author":"Lobb","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.tjpad.2025.100193_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102427","article-title":"Comparison of morphology, protein concentration, and size distribution of bone marrow and Wharton's jelly-derived mesenchymal stem cells exosomes isolated by ultracentrifugation and polymer-based precipitation techniques","volume":"88","author":"Rahmatinejad","year":"2024","journal-title":"Tissue Cell"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100193_bib0056","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0002-9440(10)64463-X","article-title":"Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology","volume":"161","author":"Takahashi","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.tjpad.2025.100193_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.884543","article-title":"Fusobacterium nucleatum infection-induced neurodegeneration and abnormal gut microbiota composition in Alzheimer's disease-like rats","volume":"16","author":"Yan","year":"2022","journal-title":"Front Neurosci"},{"issue":"07","key":"10.1016\/j.tjpad.2025.100193_bib0058","first-page":"1714","article-title":"Effects of gastrodin on cognitive impairment in Alzheimer's disease rats by regulating cAMP\/PKA\/CREB signaling pathway","volume":"44","author":"Chen","year":"2024","journal-title":"Chinese J. Gerontol."},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0059","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-019-0524-y","article-title":"Alzheimer's disease: risk factors and potentially protective measures","volume":"26","author":"Silva","year":"2019","journal-title":"J Biomed Sci"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100193_bib0060","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2174\/1567205015666180709112327","article-title":"Progressive spatial memory impairment, brain amyloid deposition and changes in serum amyloid levels as a function of age in APPswe\/PS1dE9 mice","volume":"15","author":"Fu","year":"2018","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0061","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","article-title":"Advantages and disadvantages of the use of the CSF amyloid beta (Abeta) 42\/40 ratio in the diagnosis of Alzheimer's Disease","volume":"11","author":"Hansson","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100193_bib0062","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s43587-024-00599-y","article-title":"Disease staging of Alzheimer's disease using a CSF-based biomarker model","volume":"4","author":"Salvado","year":"2024","journal-title":"Nat Aging"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100193_bib0063","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100193_bib0064","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"Plasma Abeta42\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: a cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100193_bib0065","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0066","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/alz.13583","article-title":"Blood-based biomarkers for Alzheimer's disease and cognitive function from mid- to late life","volume":"20","author":"Wang","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100193_bib0067","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.28634","article-title":"Assessment of plasma amyloid-beta42\/40 and cognitive decline among community-dwelling older adults","volume":"3","author":"Giudici","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100193_bib0068","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-Head comparison of 8 plasma amyloid-beta 42\/40 assays in Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol"},{"issue":"7691","key":"10.1016\/j.tjpad.2025.100193_bib0069","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-beta biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100193_bib0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12975-019-00755-2","article-title":"From stroke to dementia: a comprehensive review exposing tight interactions between stroke and amyloid-beta formation","volume":"11","author":"Goulay","year":"2020","journal-title":"Transl Stroke Res"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100193_bib0071","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3233\/JAD-2012-120211","article-title":"The load of amyloid-beta oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients","volume":"31","author":"Sancesario","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100193_bib0072","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jalz.2016.03.018","article-title":"Tau: from research to clinical development","volume":"12","author":"Holtzman","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100193_bib0073","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnins.2016.00031","article-title":"Tau: the center of a signaling nexus in Alzheimer's disease","volume":"10","author":"Khan","year":"2016","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0074","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jalz.2018.09.010","article-title":"Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease","volume":"15","author":"Chen","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13195-023-01201-0","article-title":"Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts","volume":"15","author":"Lantero-Rodriguez","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0076","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100193_bib0077","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100193_bib0078","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00415-023-12148-5","article-title":"Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort","volume":"271","author":"Mendes","year":"2024","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0079","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-190497","article-title":"Changes in the morphology, number, and pathological protein levels of plasma exosomes may help diagnose Alzheimer's Disease","volume":"73","author":"Sun","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline","volume":"140","author":"Lantero","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2025.100193_bib0081","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-neuro-090919-022842","article-title":"Synaptic plasticity forms and functions","volume":"43","author":"Magee","year":"2020","journal-title":"Annu Rev Neurosci"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100193_bib0082","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/alz.12582","article-title":"Synaptic density and cognitive performance in Alzheimer's disease: a PET imaging study with [(11) C]UCB-J","volume":"18","author":"Mecca","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100193_bib0083","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","article-title":"Synapse pathology in Alzheimer's disease","volume":"139","author":"Griffiths","year":"2023","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0084","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2016.02.033","article-title":"Membrane lipids in presynaptic function and disease","volume":"90","author":"Lauwers","year":"2016","journal-title":"Neuron"},{"issue":"7567","key":"10.1016\/j.tjpad.2025.100193_bib0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature14975","article-title":"Architecture of the synaptotagmin-SNARE machinery for neuronal exocytosis","volume":"525","author":"Zhou","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tjpad.2025.100193_bib0086","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fnmol.2017.00168","article-title":"Membrane Fusion involved in neurotransmission: glimpse from Electron Microscope and Molecular simulation","volume":"10","author":"Yang","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.tjpad.2025.100193_bib0087","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jconrel.2022.04.049","article-title":"Improvement of synaptic plasticity by nanoparticles and the related mechanisms: applications and prospects","volume":"347","author":"Chen","year":"2022","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100193_bib0088","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jalz.2016.04.005","article-title":"Synaptic proteins predict cognitive decline in Alzheimer's disease and lewy body dementia","volume":"12","author":"Bereczki","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0089","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(00)00285-9","article-title":"Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains","volume":"175","author":"Sze","year":"2000","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0091","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2012.03.004","article-title":"Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease","volume":"34","author":"Arnold","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100193_bib0092","doi-asserted-by":"crossref","DOI":"10.1289\/EHP10576","article-title":"Effects of DDT on Amyloid precursor protein levels and amyloid beta pathology: mechanistic links to Alzheimer's Disease risk","volume":"130","author":"Eid","year":"2022","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.tjpad.2025.100193_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117609","article-title":"Effect of Cerebralcare Granule(R) combined with memantine on Alzheimer's disease","volume":"323","author":"Yang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.tjpad.2025.100193_bib0094","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.2147\/DDDT.S402624","article-title":"Integrating network pharmacology and component analysis to study the potential mechanisms of Qi-Fu-Yin decoction in treating Alzheimer's disease","volume":"17","author":"Lei","year":"2023","journal-title":"Drug Des Devel Ther,"},{"key":"10.1016\/j.tjpad.2025.100193_bib0095","article-title":"Effects of olfactory stimulation with food and drug homology on learning and memory in AD model rats [D]","author":"Wei","year":"2023","journal-title":"Shenyang Med. Coll."},{"issue":"5","key":"10.1016\/j.tjpad.2025.100193_bib0096","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamaneurol.2016.0086","article-title":"Diagnostic and prognostic utility of the synaptic marker neurogranin in Alzheimer disease","volume":"73","author":"Tarawneh","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100193_bib0097","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-015-0161-y","article-title":"Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease","volume":"7","author":"Hellwig","year":"2015","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100193_bib0098","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jalz.2015.05.012","article-title":"C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease","volume":"11","author":"De Vos","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"21","key":"10.1016\/j.tjpad.2025.100193_bib0099","doi-asserted-by":"crossref","first-page":"e2065","DOI":"10.1212\/WNL.0000000000012853","article-title":"CSF synaptic biomarkers in the preclinical stage of Alzheimer disease and their association with MRI and PET: a cross-sectional study","volume":"97","author":"Mila-Aloma","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13195-016-0208-8","article-title":"The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease","volume":"8","author":"Ohrfelt","year":"2016","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0101","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-015-0124-3","article-title":"Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls","volume":"7","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Res Ther"},{"issue":"03","key":"10.1016\/j.tjpad.2025.100193_bib0102","first-page":"336","article-title":"Study on inflammatory aging","volume":"7","author":"Xia","year":"2012","journal-title":"J. Chengdu Med. Coll."},{"issue":"13","key":"10.1016\/j.tjpad.2025.100193_bib0103","first-page":"2575","article-title":"Cardiovascular comorbidities, inflammation, and cerebral small vessel disease","volume":"117","author":"Evans","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0104","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/cns.14047","article-title":"Plasma inflammatory biomarkers in cerebral small vessel disease: a review","volume":"29","author":"Wan","year":"2023","journal-title":"CNS Neurosci Ther"},{"issue":"7638","key":"10.1016\/j.tjpad.2025.100193_bib0105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0106","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4049\/jimmunol.1901068","article-title":"Complement-mediated events in Alzheimer's Disease: mechanisms and potential therapeutic targets","volume":"204","author":"Tenner","year":"2020","journal-title":"J Immunol"},{"issue":"6286","key":"10.1016\/j.tjpad.2025.100193_bib0107","first-page":"712","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science (1979)"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0108","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"J Immunol"},{"issue":"20","key":"10.1016\/j.tjpad.2025.100193_bib0109","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1523\/JNEUROSCI.20-20-07505.2000","article-title":"Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease","volume":"20","author":"Yang","year":"2000","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.22277","article-title":"CR1 is associated with amyloid plaque burden and age-related cognitive decline","volume":"69","author":"Chibnik","year":"2011","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100193_bib0111","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","article-title":"Systematic review of miRNA as biomarkers in Alzheimer's disease","volume":"56","author":"Swarbrick","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"16","key":"10.1016\/j.tjpad.2025.100193_bib0112","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20163979","article-title":"Role of miRNAs in Alzheimer's disease and possible fields of application","volume":"20","author":"Silvestro","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100193_bib0113","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2217\/bmm-2018-0341","article-title":"Blood circulating miRNAs as biomarkers of Alzheimer's disease: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2019","journal-title":"Biomark Med"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100193_bib0114","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22861","article-title":"Estradiol exerts a neuroprotective effect on SH-SY5Y cells through the miR-106b-5p\/TXNIP axis","volume":"35","author":"Pan","year":"2021","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112063","article-title":"Neuronal extracellular vesicles and associated microRNAs induce circuit connectivity downstream BDNF","volume":"42","author":"Antoniou","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.tjpad.2025.100193_bib0116","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.738582","article-title":"MiR-29a knockout aggravates neurological damage by pre-polarizing M1 microglia in experimental rat models of acute stroke","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Genet"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100193_bib0117","doi-asserted-by":"crossref","DOI":"10.3390\/cells12101378","article-title":"MicroRNAs in extracellular vesicles of Alzheimer's disease","volume":"12","author":"Li","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100193_bib0118","doi-asserted-by":"crossref","first-page":"833","DOI":"10.33549\/physiolres.935084","article-title":"miR-29c-3p attenuates beta-amyloid-induced neurotoxicity in Alzheimer's disease through regulating beta-site amyloid precursor protein-cleaving enzyme 1","volume":"72","author":"Wang","year":"2023","journal-title":"Physiol Res"},{"issue":"17","key":"10.1016\/j.tjpad.2025.100193_bib0119","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer's disease correlates with increased BACE1\/beta-secretase expression","volume":"105","author":"Hebert","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100193_bib0120","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.tjpad.2025.100193_bib0121","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116793","article-title":"miR-34a-5p and miR-125b-5p attenuate Abeta-induced neurotoxicity through targeting BACE1","volume":"413","author":"Li","year":"2020","journal-title":"J Neurol Sci"},{"issue":"15","key":"10.1016\/j.tjpad.2025.100193_bib0122","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.15252\/embj.201387576","article-title":"MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease","volume":"33","author":"Banzhaf-Strathmann","year":"2014","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0123","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","article-title":"MicroRNA regulation of Alzheimer's amyloid precursor protein expression","volume":"33","author":"Hebert","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0124","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1471-4159.2010.07097.x","article-title":"In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs","volume":"116","author":"Smith","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.tjpad.2025.100193_bib0125","article-title":"Integrated miRNA-seq and mRNA-seq study to identify miRNAs associated with Alzheimer's disease using post-mortem brain tissue samples","volume":"15","author":"Li","year":"2021","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0126","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41398-022-02108-4","article-title":"Differential microRNA expression analyses across two brain regions in Alzheimer's disease","volume":"12","author":"Dobricic","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0127","first-page":"1665","article-title":"MicroRNA-107 prevents amyloid-beta-induced neurotoxicity and memory impairment in mice","volume":"41","author":"Shu","year":"2018","journal-title":"Int J Mol Med"},{"issue":"6478","key":"10.1016\/j.tjpad.2025.100193_bib0128","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science (1979)"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100193_bib0129","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids\u2013the mix of hormones and biomarkers","volume":"8","author":"Cortez","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174514","article-title":"Oxygen tension regulates the miRNA profile and bioactivity of exosomes released from extravillous trophoblast cells - liquid biopsies for monitoring complications of pregnancy","volume":"12","author":"Truong","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100193_bib0131","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1007\/s12035-018-1032-x","article-title":"MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer's disease","volume":"55","author":"McKeever","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0132","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-130932","article-title":"MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease","volume":"39","author":"Kiko","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100193_bib0133","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1007\/s12035-021-02323-y","article-title":"Profiling of serum exosome MiRNA reveals the potential of a MiRNA panel as diagnostic biomarker for Alzheimer's disease","volume":"58","author":"Dong","year":"2021","journal-title":"Mol Neurobiol"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100193_bib0134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139233","article-title":"Plasma exosomal miRNAs in persons with and without Alzheimer Disease: altered expression and prospects for biomarkers","volume":"10","author":"Lugli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tjpad.2025.100193_bib0135","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuroscience.2020.02.044","article-title":"Profile of pathogenic proteins and MicroRNAs in plasma-derived extracellular vesicles in Alzheimer's Disease: a pilot study","volume":"432","author":"Li","year":"2020","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100193_bib0136","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/13813455.2020.1734842","article-title":"Downregulation of serum miR-106b: a potential biomarker for Alzheimer disease","volume":"128","author":"Madadi","year":"2022","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0137","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.expneurol.2011.11.026","article-title":"Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease","volume":"235","author":"Geekiyanage","year":"2012","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0138","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","article-title":"On the path to 2025: understanding the Alzheimer's disease continuum","volume":"9","author":"Aisen","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100193_bib0139","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tins.2008.12.003","article-title":"Alterations of the microRNA network cause neurodegenerative disease","volume":"32","author":"Hebert","year":"2009","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100193_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0250-2","article-title":"Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exp Mol Med"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100193_bib0141","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00688261","article-title":"Olfactory bulb changes in Alzheimer's disease","volume":"73","author":"Ohm","year":"1987","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100193_bib0142","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.0000000000001132","article-title":"Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community","volume":"84","author":"Devanand","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100193_bib0143","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.neurobiolaging.2008.09.008","article-title":"Olfactory identification deficits and MCI in a multi-ethnic elderly community sample","volume":"31","author":"Devanand","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"19","key":"10.1016\/j.tjpad.2025.100193_bib0144","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","article-title":"Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later","volume":"80","author":"Roe","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100193_bib0145","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","article-title":"Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study","volume":"12","author":"Vos","year":"2013","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100193_bib0146","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100193_bib0147","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/alz.12570","article-title":"CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: implications for clinical trial design","volume":"18","author":"Moscoso","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100193_bib0148","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1093\/brain\/awx256","article-title":"Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons","volume":"140","author":"Rodriguez-Rodriguez","year":"2017","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100193_bib0149","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/cdd.2008.188","article-title":"GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986","volume":"16","author":"Gupta","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.tjpad.2025.100193_bib0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fnsyn.2016.00007","article-title":"SNAP-25, a known presynaptic protein with emerging postsynaptic functions","volume":"8","author":"Antonucci","year":"2016","journal-title":"Front Synaptic Neurosci"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100193_bib0151","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/s43587-023-00490-2","article-title":"APOEepsilon4 potentiates amyloid beta effects on longitudinal tau pathology","volume":"3","author":"Ferrari-Souza","year":"2023","journal-title":"Nat Aging"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100193_bib0152","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100193_bib0153","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/med.21394","article-title":"The role of Cathepsin D in the pathogenesis of Human neurodegenerative disorders","volume":"36","author":"Vidoni","year":"2016","journal-title":"Med Res Rev"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100193_bib0154","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010138","article-title":"Identification of Cathepsin D as a plasma biomarker for Alzheimer's Disease","volume":"10","author":"Kim","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100193_bib0155","doi-asserted-by":"crossref","DOI":"10.3390\/biom11070980","article-title":"Brain-derived exosomal proteins as effective biomarkers for Alzheimer's Disease: a systematic review and meta-analysis","volume":"11","author":"Kim","year":"2021","journal-title":"Biomolecules"},{"issue":"15","key":"10.1016\/j.tjpad.2025.100193_bib0156","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.7150\/thno.74305","article-title":"Small extracellular vesicles isolation and separation: current techniques, pending questions and clinical applications","volume":"12","author":"Jia","year":"2022","journal-title":"Theranostics"},{"issue":"17","key":"10.1016\/j.tjpad.2025.100193_bib0157","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1039\/D1LC00443C","article-title":"Advances in microfluidic extracellular vesicle analysis for cancer diagnostics","volume":"21","author":"Cheng","year":"2021","journal-title":"Lab Chip"},{"key":"10.1016\/j.tjpad.2025.100193_bib0158","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.2147\/IJN.S421342","article-title":"Application of single extracellular vesicle analysis techniques","volume":"18","author":"Zhu","year":"2023","journal-title":"Int J Nanomedicine"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725001384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725001384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:15:55Z","timestamp":1762614955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725001384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":158,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2274580725001384"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100193","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of blood neural cell-derived small extracellular vesicles in the diagnosis and prediction of Alzheimer's disease: A systematic review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100193"}}